Ypsomed is the leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist. The company will celebrate its 40th anniversary in 2024. As a leader in innovation and technology, it is a preferred partner of pharmaceutical and biotech companies for pens, autoinjectors and pump systems for administering liquid medications. Ypsomed presents and markets its product portfolios under the umbrella brand mylife Diabetescare directly to patients, pharmacies and hospitals as well as under Ypsomed Delivery Systems in business-to-business operations with pharmaceutical companies. Ypsomed is headquartered in Burgdorf, Switzerland. The company has a global network of production facilities, subsidiaries and distribution partners. Ypsomed has over 2,200 employees worldwide.
View Top Employees from Ypsomed AGWebsite | https://www.ypsomed.com/en/company/ypsostories.html |
Ticker | YPSN |
Revenue | $477 million |
Employees | 1,390 (959 on RocketReach) |
Founded | 2003 |
Address | 6 Brunnmattstrasse, Burgdorf, Bern 3401, CH |
Phone | +41 34 424 41 11 |
Fax | +41 34 424 41 22 |
Technologies |
JavaScript,
HTML,
Twitter
+33 more
(view full list)
|
Industry | Medical Equipment Manufacturing, Pharmaceuticals, Medical Device, Diabetes Care, Healthcare, Health Care, Manufacturer, Injection Systems, Selfcare Solutions, Blood Glucose Monitoring Systems |
Web Rank | 1 Million |
Keywords | Drug Development And Manufacturing |
Competitors | Concorde-Corodex Group, Insulet Corporation, NEMERA, STABILO International GmbH, Stanadyne Diesel Systems |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 4461 Companies, NAICS Code 446 Companies, NAICS Code 44 Companies |
Looking for a particular Ypsomed AG employee's phone or email?
The Ypsomed AG annual revenue was $477 million in 2024.
959 people are employed at Ypsomed AG.
Ypsomed AG is based in Burgdorf, Bern.
The NAICS codes for Ypsomed AG are [4461, 446, 44].
The SIC codes for Ypsomed AG are [28, 283].